{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:55:01Z","timestamp":1791082501641,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.nbd.2026.107582","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:21:33Z","timestamp":1787552493000},"page":"107582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Splicing modulation of ATXN2 as a therapeutic strategy to regulate Ataxin-2 protein levels in ALS"],"prefix":"10.1016","volume":"229","author":[{"given":"Nicolette","family":"Heinsinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Grauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Simov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bukhtiyarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Parish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Meier","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Uslaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nbd.2026.107582_bb0005","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1038\/s41467-025-60497-8","article-title":"AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice","volume":"16","author":"Amado","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.nbd.2026.107582_bb0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2007.12.003","article-title":"Stress granules: the Tao of RNA triage","volume":"33","author":"Anderson","year":"2008","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"10.1016\/j.nbd.2026.107582_bb0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ymeth.2010.11.006","article-title":"TDP-43 toxicity in yeast","volume":"53","author":"Armakola","year":"2011","journal-title":"Methods"},{"key":"10.1016\/j.nbd.2026.107582_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104639","article-title":"Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum","volume":"134","author":"Baradaran-Heravi","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"7650","key":"10.1016\/j.nbd.2026.107582_bb0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature22038","article-title":"Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice","volume":"544","author":"Becker","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.nbd.2026.107582_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tibs.2012.03.003","article-title":"TDP-43: gumming up neurons through protein-protein and protein-RNA interactions","volume":"37","author":"Buratti","year":"2012","journal-title":"Trends Biochem. Sci."},{"issue":"10","key":"10.1016\/j.nbd.2026.107582_bb0035","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41573-022-00521-4","article-title":"Targeting RNA structures with small molecules","volume":"21","author":"Childs-Disney","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7310","key":"10.1016\/j.nbd.2026.107582_bb0040","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.nbd.2026.107582_bb0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40478-025-02005-z","article-title":"Viral-mediated knockdown of Atxn2 attenuates TDP-43 pathology and muscle dysfunction in the PFN1(C71G) ALS mouse model","volume":"13","author":"Hawley","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.nbd.2026.107582_bb0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12017-025-08871-z","article-title":"A slower-progressing TDP-43 rNLS8 mouse model for ALS: implications for preclinical and mechanistic studies","volume":"27","author":"Jagaraj","year":"2025","journal-title":"Neuromolecular Med."},{"issue":"3","key":"10.1016\/j.nbd.2026.107582_bb0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1083\/jcb.201302044","article-title":"Stress granules as crucibles of ALS pathogenesis","volume":"201","author":"Li","year":"2013","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.nbd.2026.107582_bb0060","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.nbd.2026.107582_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013250","article-title":"Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue","volume":"5","author":"Liu-Yesucevitz","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.nbd.2026.107582_bb0070","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1038\/s41380-023-02036-9","article-title":"Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD","volume":"28","author":"Luan","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.nbd.2026.107582_bb0075","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6197","key":"10.1016\/j.nbd.2026.107582_bb0080","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"issue":"5796","key":"10.1016\/j.nbd.2026.107582_bb0085","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.nbd.2026.107582_bb0090","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","article-title":"SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice","volume":"11","author":"Palacino","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2026.107582_bb0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.nbd.2018.11.013","article-title":"Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP-43-triggered death in rNLS8 mice","volume":"124","author":"Spiller","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107582_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105548","article-title":"Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology","volume":"161","author":"Tian","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.nbd.2026.107582_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0308428","article-title":"Deciphering the interactome of Ataxin-2 and TDP-43 in iPSC-derived neurons for potential ALS targets","volume":"19","author":"Tian","year":"2024","journal-title":"PloS One"},{"issue":"21","key":"10.1016\/j.nbd.2026.107582_bb0110","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1111\/bph.17308","article-title":"Targeting RNA with small molecules, from RNA structures to precision medicines: IUPHAR review: 40","volume":"181","author":"Tong","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.nbd.2026.107582_bb0115","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00401-015-1460-x","article-title":"Functional recovery in new mouse models of ALS\/FTLD after clearance of pathological cytoplasmic TDP-43","volume":"130","author":"Walker","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.nbd.2026.107582_bb0120","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1111\/ejn.15422","article-title":"Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis","volume":"54","author":"Wright","year":"2021","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2026.107582_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42147-z","article-title":"Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins","volume":"14","author":"Zeballos","year":"2023","journal-title":"Nat. Commun."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612600327X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999612600327X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:46:15Z","timestamp":1791081975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999612600327X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":25,"alternative-id":["S096999612600327X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107582","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splicing modulation of ATXN2 as a therapeutic strategy to regulate Ataxin-2 protein levels in ALS","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107582"}}